Legal Representation
Attorney
Craig Kuchii
USPTO Deadlines
Application History
46 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 18, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Oct 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 18, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Oct 18, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Oct 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 27, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 27, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Mar 27, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Oct 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 18, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 18, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 18, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Oct 18, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Oct 18, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 17, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Oct 17, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Oct 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 14, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Apr 6, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 4, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Apr 4, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Apr 4, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 17, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 17, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Oct 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 19, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 6, 2022 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
Feb 23, 2022 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
Feb 14, 2022 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
Feb 1, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
Nov 24, 2021 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
Oct 26, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 26, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 6, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 22, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 16, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
Sep 15, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Sep 8, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Aug 25, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 25, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 25, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 23, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 5, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 5, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
Classification
International Classes
005